These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27774327)

  • 1. Poor Outcomes in Hepatic Amyloidosis: A Report of 2 Cases.
    Yim B; Kertowidjojo E; Zhang Y; Patel P
    Case Rep Oncol Med; 2016; 2016():7625940. PubMed ID: 27774327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of Bortezomib Chemotherapy in Hepatic Amyloidosis.
    Hasan SM; Ahmed NN; Ahmed Z; Seibert A
    J Investig Med High Impact Case Rep; 2018; 6():2324709618760079. PubMed ID: 29552568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globular hepatic amyloid--an unusual morphologic presentation.
    Kanel GC; Uchida T; Peters RL
    Hepatology; 1981; 1(6):647-52. PubMed ID: 7308997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Involvement as the Sole Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis: A Diagnostic Challenge.
    Kottavadakkeel N; Rajaram A
    Cureus; 2023 Oct; 15(10):e47310. PubMed ID: 38022076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare Complication of a Rare Malignancy: Case Report of Cardiac Amyloidosis Secondary to Waldenstrom Macroglobulinemia.
    Charles Lobo A; Bhat V; Anandram S; Devi A M S; Rao SS; Vinister GV; Lobo V; Reuben Ross C
    Qatar Med J; 2022; 2022(1):7. PubMed ID: 35382435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent diarrhea with petechial rash - unusual pattern of light chain amyloidosis deposition on skin and gastrointestinal biopsies: A case report.
    Bilton SE; Shah N; Dougherty D; Simpson S; Holliday A; Sahebjam F; Grider DJ
    World J Clin Cases; 2022 Oct; 10(28):10252-10259. PubMed ID: 36246794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic amyloidosis--two cases report.
    Jeong HJ; Hahn EK; Kim E; Park CI
    J Korean Med Sci; 1988 Dec; 3(4):151-5. PubMed ID: 3267363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Severe Cholestasis due to Hepatic AL Amyloidosis.
    Dias T; Ferreira D; Moreira H; Nascimento T; Santos A; Carvalho A
    GE Port J Gastroenterol; 2019 Oct; 26(6):425-429. PubMed ID: 31832498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients.
    Gertz MA; Kyle RA
    Am J Med; 1988 Jul; 85(1):73-80. PubMed ID: 3389383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic amyloidosis as a rare differential diagnosis of progressive liver failure].
    Bettinger D; Lutz L; Schultheiß M; Werner M; Thimme R; Neumann-Haefelin C
    Dtsch Med Wochenschr; 2016 Sep; 141(19):1387-9. PubMed ID: 27642740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic Amyloidosis as a Rare Cause of Liver Failure: A Case Report.
    Ghazanfar H; Khaja M; Haider A; Yapor L; Kandhi S; Sulh M
    Cureus; 2022 Jul; 14(7):e27274. PubMed ID: 36039232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hepatic amyloidosis: A case report and review of literature.
    Sonthalia N; Jain S; Pawar S; Zanwar V; Surude R; Rathi PM
    World J Hepatol; 2016 Feb; 8(6):340-4. PubMed ID: 26962400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group.
    Mauermann ML; Clarke JO; Litchy WJ; Obici L; Lousada I; Gertz MA;
    Adv Ther; 2023 Nov; 40(11):4695-4710. PubMed ID: 37658177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
    Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN
    Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease.
    Dias E; Cardoso H; Marques M; Liberal R; Lopes S; Pereira P; Santos-Antunes J; Pinheiro J; Lopes J; Carneiro F; Macedo G
    Rev Esp Enferm Dig; 2023 Jan; 115(1):16-21. PubMed ID: 35297258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hepatic amyloidosis presenting as nodular masses on the background of diffuse infiltration and extreme liver stiffness on MR elastography.
    Srinivasan S; Tan YQ; Teh HS; Lee PJ; Khoo RN
    J Gastrointestin Liver Dis; 2014 Dec; 23(4):437-40. PubMed ID: 25532004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases.
    Makhlouf HR; Goodman ZD
    Am J Surg Pathol; 2007 Oct; 31(10):1615-21. PubMed ID: 17895765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized amyloidosis: A diagnostic pitfall in breast pathology.
    Lytle A; Darvishian F; Ozerdem U
    Pathol Res Pract; 2019 Dec; 215(12):152699. PubMed ID: 31708371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographic Distribution Pattern in Hepatic Amyloidosis Presenting with Portal Hypertension.
    Nigam N; Rastogi A; Bhatt P; Bihari C
    J Clin Exp Hepatol; 2023; 13(2):259-264. PubMed ID: 36950500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
    Park MA; Mueller PS; Kyle RA; Larson DR; Plevak MF; Gertz MA
    Medicine (Baltimore); 2003 Sep; 82(5):291-8. PubMed ID: 14530778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.